Global COPD Drug Market Professional Survey Report 2016
- QYR596775
- 107 Pages
- June 2016
- Pharmaceuticals
Product types including
Bronchodilators
Biological Drugs
Other
The segment applications including
Hospital use
Clinic use
Household
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
GSK
Novartis
Boehringer Ingelheim
Pfizer, Inc.
AstraZeneca
Boehringer Ingelheim
Bayer
Chiesi Farmaceutici
Forest Laboratories
Lallemand Pharma
Merck & Co
Sunovion Pharmaceuticals
Amgen Inc.
Cornerstone Therapeutics
Forest Laboratories, Inc.
Medicis Pharmaceutical
Teva Pharmaceutical Industries, Ltd.
With 17 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of COPD Drug
1.1 Definition and Specifications of COPD Drug
1.1.1 Definition of COPD Drug
1.1.2 Specifications of COPD Drug
1.2 Classification of COPD Drug
1.2.1 Bronchodilators
1.2.2 Biological Drugs
1.2.3 Other
1.3 Applications of COPD Drug
1.3.1 Hospital use
1.3.2 Clinic use
1.3.3 Household
1.4 Industry Chain Structure of COPD Drug
1.5 Industry Overview and Major Regions Status of COPD Drug
1.5.1 Industry Overview of COPD Drug
1.5.2 Global Major Regions Status of COPD Drug
1.6 Industry Policy Analysis of COPD Drug
1.7 Industry News Analysis of COPD Drug
2 Manufacturing Cost Structure Analysis of COPD Drug
2.1 Raw Material Suppliers and Price Analysis of COPD Drug
2.2 Equipment Suppliers and Price Analysis of COPD Drug
2.3 Labor Cost Analysis of COPD Drug
2.4 Other Costs Analysis of COPD Drug
2.5 Manufacturing Cost Structure Analysis of COPD Drug
2.6 Manufacturing Process Analysis of COPD Drug
3 Technical Data and Manufacturing Plants Analysis of COPD Drug
3.1 Capacity and Commercial Production Date of Global COPD Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global COPD Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global COPD Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global COPD Drug Major Manufacturers in 2015
4 Global COPD Drug Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global COPD Drug Capacity and Growth Rate Analysis
4.2.2 2015 COPD Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global COPD Drug Sales and Growth Rate Analysis
4.3.2 2015 COPD Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global COPD Drug Sales Price
4.4.2 2015 COPD Drug Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global COPD Drug Gross Margin
4.5.2 2015 COPD Drug Gross Margin Analysis (Company Segment)
5 COPD Drug Regional Market Analysis
5.1 North America COPD Drug Market Analysis
5.1.1 North America COPD Drug Market Overview
5.1.2 North America 2011-2016E COPD Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E COPD Drug Sales Price Analysis
5.1.4 North America 2015 COPD Drug Market Share Analysis
5.2 Europe COPD Drug Market Analysis
5.2.1 Europe COPD Drug Market Overview
5.2.2 Europe 2011-2016E COPD Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E COPD Drug Sales Price Analysis
5.2.4 Europe 2015 COPD Drug Market Share Analysis
5.3 Japan COPD Drug Market Analysis
5.3.1 Japan COPD Drug Market Overview
5.3.2 Japan 2011-2016E COPD Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E COPD Drug Sales Price Analysis
5.3.4 Japan 2015 COPD Drug Market Share Analysis
5.4 China COPD Drug Market Analysis
5.4.1 China COPD Drug Market Overview
5.4.2 China 2011-2016E COPD Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E COPD Drug Sales Price Analysis
5.4.4 China 2015 COPD Drug Market Share Analysis
5.5 Southeast Asia COPD Drug Market Analysis
5.5.1 Southeast Asia COPD Drug Market Overview
5.5.2 Southeast Asia 2011-2016E COPD Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E COPD Drug Sales Price Analysis
5.5.4 Southeast Asia 2015 COPD Drug Market Share Analysis
5.6 India COPD Drug Market Analysis
5.6.1 India COPD Drug Market Overview
5.6.2 India 2011-2016E COPD Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E COPD Drug Sales Price Analysis
5.6.4 India 2015 COPD Drug Market Share Analysis
6 Global 2011-2016E COPD Drug Segment Market Analysis (by Type)
6.1 Global 2011-2016E COPD Drug Sales by Type
6.2 Different Types COPD Drug Product Interview Price Analysis
6.3 Different Types COPD Drug Product Driving Factors Analysis
6.3.1 Bronchodilators COPD Drug Growth Driving Factor Analysis
6.3.2 Biological Drugs COPD Drug Growth Driving Factor Analysis
6.3.3 Other COPD Drug Growth Driving Factor Analysis
7 Global 2011-2016E COPD Drug Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use COPD Drug Growth Driving Factor Analysis
7.3.2 Clinic use COPD Drug Growth Driving Factor Analysis
7.3.3 Household COPD Drug Growth Driving Factor Analysis
8 Major Manufacturers Analysis of COPD Drug
8.1 GSK
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 GSK 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 GSK 2015 COPD Drug Business Region Distribution Analysis
8.2 Novartis
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Novartis 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Novartis 2015 COPD Drug Business Region Distribution Analysis
8.3 Boehringer Ingelheim
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Boehringer Ingelheim 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Boehringer Ingelheim 2015 COPD Drug Business Region Distribution Analysis
8.4 Pfizer, Inc.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Pfizer, Inc. 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Pfizer, Inc. 2015 COPD Drug Business Region Distribution Analysis
8.5 AstraZeneca
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 AstraZeneca 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 AstraZeneca 2015 COPD Drug Business Region Distribution Analysis
8.6 Boehringer Ingelheim
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Boehringer Ingelheim 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Boehringer Ingelheim 2015 COPD Drug Business Region Distribution Analysis
8.7 Bayer
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Bayer 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Bayer 2015 COPD Drug Business Region Distribution Analysis
8.8 Chiesi Farmaceutici
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Chiesi Farmaceutici 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Chiesi Farmaceutici 2015 COPD Drug Business Region Distribution Analysis
8.9 Forest Laboratories
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Forest Laboratories 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Forest Laboratories 2015 COPD Drug Business Region Distribution Analysis
8.10 Lallemand Pharma
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Lallemand Pharma 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Lallemand Pharma 2015 COPD Drug Business Region Distribution Analysis
8.11 Merck & Co
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Merck & Co 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Merck & Co 2015 COPD Drug Business Region Distribution Analysis
8.12 Sunovion Pharmaceuticals
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Sunovion Pharmaceuticals 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Sunovion Pharmaceuticals 2015 COPD Drug Business Region Distribution Analysis
8.13 Amgen Inc.
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Amgen Inc. 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Amgen Inc. 2015 COPD Drug Business Region Distribution Analysis
8.14 Cornerstone Therapeutics
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Cornerstone Therapeutics 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Cornerstone Therapeutics 2015 COPD Drug Business Region Distribution Analysis
8.15 Forest Laboratories, Inc.
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Forest Laboratories, Inc. 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Forest Laboratories, Inc. 2015 COPD Drug Business Region Distribution Analysis
8.16 Medicis Pharmaceutical
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Medicis Pharmaceutical 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Medicis Pharmaceutical 2015 COPD Drug Business Region Distribution Analysis
8.17 Teva Pharmaceutical Industries, Ltd.
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Teva Pharmaceutical Industries, Ltd. 2015 COPD Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Teva Pharmaceutical Industries, Ltd. 2015 COPD Drug Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 COPD Drug Consumption Forecast
9.2.2 Europe 2016-2021 COPD Drug Consumption Forecast
9.2.3 Japan 2016-2021 COPD Drug Consumption Forecast
9.2.4 China 2016-2021 COPD Drug Consumption Forecast
9.2.5 Southeast Asia 2016-2021 COPD Drug Consumption Forecast
9.2.6 India 2016-2021 COPD Drug Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 COPD Drug Marketing Model Analysis
10.1 COPD Drug Regional Marketing Model Analysis
10.2 COPD Drug International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of COPD Drug by Regions
10.4 COPD Drug Supply Chain Analysis
11 Consumers Analysis of COPD Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of COPD Drug
12.1 New Project SWOT Analysis of COPD Drug
12.2 New Project Investment Feasibility Analysis of COPD Drug
13 Conclusion of the Global COPD Drug Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
